Journal Article

A review of economic evaluations of health care for people at risk of psychosis and for first-episode psychosis

Davies, Linda M., Byrne, Rory, Buck, Deborah, Broome, Matthew R., Husain, Nusrat, Shields, Gemma E., Varese, Filippo, Yung, Alison R., Thompson, Andrew, Upthegrove, Rachel

2022

Overview

Background Preventing psychotic disorders and effective treatment in first-episode psychosis are key priorities for the National Institute for Health and Care Excellence. This review assessed the evidence base for the cost-effectiveness of health and social care interventions for people at risk of psychosis and for first-episode psychosis. Methods Electronic searches were conducted using the PsycINFO, MEDLINE and Embase databases to identify relevant published full economic evaluations published before August 2020. Full-text English-language studies reporting a full economic evaluation of a health or social care intervention aiming to reduce or prevent symptoms in people at risk of psychosis or experiencing first-episode psychosis were included. Screening, data extraction, and critical appraisal were performed using pre-specified criteria and forms based on the NHS Economic Evaluation Database (EED) handbook and Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist for economic evaluations. The protocol was registered on the PROSPERO database (CRD42018108226). Results were summarised qualitatively. Results Searching identified 1,628 citations (1,326 following the removal of duplications). After two stages of screening 14 studies met the inclusion criteria and were included in the review. Interventions were varied and included multidisciplinary care, antipsychotic medication, psychological therapy, and assertive outreach. Evidence was limited in the at-risk group with only four identified studies, though all interventions were found to be cost-effective with a high probability (> 80%). A more substantial evidence base was identified for first-episode psychosis (11 studies), with a focus on early intervention (7/11 studies) which again had positive conclusions though with greater uncertainty. Conclusions Study findings generally concluded interventions were cost-effective. The evidence for the population who are at-risk of psychosis was limited, and though there were more studies for the population with first-episode psychosis, limitations of the evidence base (including generalisability and heterogeneity across the methods used) affect the certainty of conclusions.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Antipsychotic Agents / Antipsychotics / Care and treatment / Child & adolescent mental health / Cost control / Cost-Benefit Analysis / Cost-effectiveness / Cost-utility / Delivery of Health Care / Early intervention / Economic aspects / Economic evaluation / Evaluation / Health care / Humans / Medical care, Cost of / Medicine / Medicine & Public Health / Medicine, Preventive / Mental disorders / Mental health care / Population studies / Prevention / Preventive health services / Psychiatric services / Psychiatry / Psychoses / Psychosis / Psychotherapy / Psychotic Disorders - therapy / Reviews / Systematic review / Treatment Outcome